NCT01923558View on ClinicalTrials.gov

Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

November 30, 2010

Conditions
Healthy
Interventions
DRUG

Donepezil

Donepezil Hydrochloride tablets,23 mg

Trial Locations (1)

H3P 3P1

Algorithme Pharma Inc., Mount Royal

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY